Matrix Metalloproteinase (MMP) in Heart Failure
MMP is Produced in Failing Hearts
1 other identifier
observational
22
0 countries
N/A
Brief Summary
The purpose of this study is to evaluate the production of MMP in failing hearts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2003
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2006
CompletedFirst Submitted
Initial submission to the registry
April 18, 2008
CompletedFirst Posted
Study publicly available on registry
April 22, 2008
CompletedJuly 21, 2011
April 1, 2008
April 18, 2008
July 20, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
MMPs level of coronary sinus
Eligibility Criteria
chronic heart failure
You may qualify if:
- chronic stable heart failure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 18, 2008
First Posted
April 22, 2008
Study Start
February 1, 2003
Study Completion
July 1, 2006
Last Updated
July 21, 2011
Record last verified: 2008-04